Nilotinib differentially affects oligomeric alpha-synuclein and reduces phosphorylated neurofilaments and motor symptoms in Parkinson's disease with dementia and Lewy Body dementia.  

 -  2017 
<br/><br/><label>Index Terms--Curriculum Objective: </label><br/>Poster presented at